Hybrid Public Workshop: Artificial Intelligence in Drug & Biological Product Development Fecha y hora6 ago 2024 11:00 a. m.

https://duke.zoom.us/meeting/register/tJcrcu-qrTMiHdayh1J3JhkCi6XkvmAIFey6?utm_medium=email&utm_source=govdelivery#/registration FDA and CTTI to Host a Public Workshop on AI in Drug & Biological Product Development On Tuesday August 6, 2024 from 10 AM to 5:30 PM EDT, the FDA and the Clinical Trials Transformation Initiative are hosting a hybrid public workshop on artificial intelligence (AI) in drug and biological product development. The public workshop is free to attend. Please join us as we explore the guiding principles that are being applied by innovators and regulators to ensure AI is used responsibly in the field of AI. AI holds great potential to transform how drugs are developed, manufactured, and utilized. Participants have the option to attend virtually or in-person in the FDA Great Room located at 10903 New Hampshire Avenue, Silver Spring, MD 20993. Registration information can be found here.